-
NSF Funding Data Mining for Depression Diagnosis
A computer scientist at University of Texas in Arlington is developing data mining techniques and algorithms to help clinicians analyze unstructured notes accumulated from patients in therapy for depression.
-
Biopharm Company Raising $40 Million in IPO
Omeros Corporation, a biopharmaceutical company developing drugs that prevent inflammation in surgeries, is raising $40 million in its initial public stock offering.
-
New System Measures Oxygen Levels in ICU Patients
Researchers at University of Oxford in the U.K. designed a device that measures oxygen consumption in critically ill patients, to prevent occurrence of shock.
-
Patent Advances for Gut Damage Treatment Delivery
A developer of therapies for damage to an intestinal barrier received a notice that the U.S. intends to issue a patent protecting the technology to deliver the treatments.
-
Chip Device Simulates Blood Vessels in Clotting
Researchers at a Harvard University bioengineering center developed a plastic chip that simulates critical interactions between tissue lining blood vessels and platelets that affect the flow of blood.
-
Stanford, Google Partner on Genomic Health Analysis
Stanford University’s medical departments and Google’s cloud service are collaborating on a plan to make genomics a more routine part of health care.
-
NIH Funding Trial of Precise Tumor Removal System
A company making a system to guide surgery that promises more complete removal of breast tumors received funding for a large-scale clinical trial testing the technology.
-
Stem Cells Banked for Bipolar Disorder Research
Stem cells from people with bipolar disorder are being collected by an academic-industry partnership for scientists worldwide who study the disorder.
-
Cocaine Vaccine Trial Recruitment Underway
An early-stage clinical trial testing a vaccine designed to prevent cocaine from reaching the brain started recruiting participants in New York.
-
FDA Clears Thin, Transparent Wound Dressing Material
The Food and Drug Administration cleared a new type of thin, transparent wound dressing for marketing in the U.S. as a medical device.